Avanos Medical, Inc. (AVNS) Tops Q4 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St futures ease as Big Tech results revive AI spending worries; oil jumps
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- Dollar hits fresh 40-year high versus yen, edges down against euro
- Oil prices rise for a fifth day as US-Iran hostilities threaten supply routes
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2018 Results, Provides 2019 Outlook
February 26, 2019 7:02 AM ESTALPHARETTA, Ga., Feb. 26, 2019 /PRNewswire/ --Â Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2018 results.
"2018 was a year of continued momentum and achievement, highlighted by strong growth in our Interventional Pain and Chronic Care businesses, the close of the S&IP divestiture and the Game Ready acquisition, and the acceleration of investments for future growth. Additionally, we initiated aggressive action to ensure our cost structure effectively supports our continued growth as a more agile, pure-play medical device company," said Joe Woody, Avanos chief executive... More
